Rapid urinary lipoarabinomannan test with laboratory-level sensitivity for tuberculosis detection: a performance evaluation
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.03042-25 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Qisheng Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Brightest Bio, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Tuberculosis, Diagnostic Tests, Routine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Developing rapid, non-sputum-based tests is a global priority to improve the diagnosis and timely treatment of tuberculosis (TB). In this study, we evaluated the detection limit, precision, stability, and lot-to-lot variation of a next-generation rapid diagnostic test (RDT), the plasmonic fluor (PF)-enhanced urinary lipoarabinomannan lateral flow assay (PF-LAM). We also assessed the diagnostic performance of PF-LAM, Alere Determine TB LAM Ag (AlereLAM), and electrochemiluminescence LAM assay (EclLAM), a highly sensitive laboratory-based test by comparing with microbiology reference standard (MRS) that includes molecular testing (Xpert MTB/RIF) and culture. Two sub-studies were conducted using banked urine samples. First, a preclinical study involving 399 well-characterized urine samples was conducted to determine assay cutoff and assess PF-LAM performance compared with Alere LAM. Second, a diagnostic accuracy assessment study was conducted using 77 blinded samples to compare the performance of PF-LAM to EclLAM. In the preclinical study, when compared with MRS, the AlereLAM showed a sensitivity of 5.5% (95% CI: 3.1%–9.6%) and a specificity of 98.5% (95% CI: 95.6%–99.6%), while PF-LAM exhibited a sensitivity of 33.8% (95% CI: 27.4%–40.6%) and the same specificity of 98.5% (95% CI: 95.6%–99.6%). In the diagnostic accuracy study, when compared with MRS, PF-LAM achieved a sensitivity of 58% (95% CI: 41%–73%) and a specificity of 98% (95% CI: 88%–100%), while EclLAM showed a sensitivity of 42% (95% CI: 27%–59%) and a specificity of 95% (95% CI: 85%–99%). Overall, PF-LAM demonstrated better analytical and diagnostic sensitivity compared with EclLAM and significantly better performance compared with AlereLAM, while exhibiting high precision and minimal lot-to-lot variability. IMPORTANCE To the best of our knowledge, this study uniquely reports a rapid diagnostic test, plasmonic fluor-enhanced urinary lipoarabinomannan lateral flow assay (PF-LAM), outperforming an electrochemiluminescence-based laboratory assay. PF-LAM demonstrated promising analytical and diagnostic performance with minimal lot-to-lot variability, positioning it as a helpful tool for non-sputum tuberculosis diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brightest Bio, Saint Louis, Missouri, USA.
- FIND, the global alliance for diagnostics, Geneva, Switzerland.
- Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Mechanical and Aerospace Engineering, University of Houston, Houston, Texas, USA.
- PATH, Seattle, Washington, USA.
- Department of Mechanical Engineering and Materials Science, Institute of Materials Science and Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.
ORCID-Profile: Qisheng Jiang, Sumanth Gandra, Srikanth Singamaneni
Zitieren
APA
Jiang, Q., Ramachandraiah, H., Duncan, C., Gandra, S., George, I. A., Luan, J., Perez, M., Lillis, L., Boyle, D. S., Crick, S., Ruhwald, M., & Singamaneni, S. (2026). Rapid urinary lipoarabinomannan test with laboratory-level sensitivity for tuberculosis detection: a performance evaluation. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03042-25
Vancouver
Jiang Q, Ramachandraiah H, Duncan C, Gandra S, George IA, Luan J, et al. Rapid urinary lipoarabinomannan test with laboratory-level sensitivity for tuberculosis detection: a performance evaluation. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03042-25
BibTeX
@article{Jiang2026,
author = {Jiang, Qisheng and Ramachandraiah, Harisha and Duncan, Carolyn and Gandra, Sumanth and George, Ige A and Luan, Jingyi and Perez, Marcos and Lillis, Lorraine and Boyle, David S and Crick, Scott and Ruhwald, Morten and Singamaneni, Srikanth},
title = {Rapid urinary lipoarabinomannan test with laboratory-level sensitivity for tuberculosis detection: a performance evaluation},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.03042-25}
}
EUVIMED